Todd E. Druley

Todd E. Druley, MD, PhD

Specializes In
  • Blood Disorders (Hematology)
  • Cancer (Oncology)
  • Pediatric Cancer
Languages Spoken
  • English


Sees Patients For

Pediatric cancer, pediatric blood disorders, pediatric brain tumor, pediatric oncology, pediatrics; cancer predisposition

Hospital Affiliations

  • St. Louis Children's Hospital



Board Certifications

  • Pediatrics
  • Pediatric Hematology
  • Pediatric Oncology

Academic Title(s)

Assistant Professor, Pediatrics
Division of Hematology and Oncology

Research Interests

Developing targeted high throughput pooled sample DNA sequencing, designed to detect rare germline variants in specific genes involved in pediatric carcinogenesis, as well as the general population.

Publications & Research

Search PubMed for publications »



2002 University of Illinois at Chicago, Chicago, Illinois


2005 Pediatrics, St. Louis Children's Hospital at Washington University School of Medicine, St. Louis, Missouri


1994 Cell and Structural Biology, University of Illinois at Urbana-Champaign, Chicago, Illinois

Medical Degree

2002 University of Illinois at Chicago, Chicago, Illinois


2008 Pediatric Hematology and Oncology, Washington University School of Medicine, St. Louis, Missouri

Financial Disclosures
  • ArcherDX, Inc.,
    • Equity: Yes
    • Consulting/Advisory Board: $40,000 - $59,999
    • Reporting Date: 05/01/2021

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.